cstavish
Joined 15 years ago
Joined 15 years ago
For some use-cases, deploying AI to microscopic fields of view is a viable, lower-cost alternative to creating whole-slide images and running AI on them in their entirety (whole-slide scanners are a bit expensive). Specifically, if a pathologists identifies a suspicious region, the augmented scope can provide useful support. However, many types of anatomic pathology assessment require laborious review of several slides. Only AI applied to whole-slide images can pre-identify rare events or "hot spots", saving pathologist time while improving diagnostic confidence.
There's generally minimal liquidity. During a round, an existing investor may have the opportunity to sell some shares to new/other investors, but if she knows something that's not coming out during diligence, there's definitely something fishy going on. If the round is shaping up to be a major up-round, maybe an early investor wants to lock in a good return, but that's beside the point here. And then of course if things really aren't going well for the company, you're looking at the bad kind of liquidity event--a liquidation.
So if a VC wants to pull out based on a negative hunch, it's probably either impossible or the signal itself will doom the company if it wasn't already doomed.
Just my 2 cents as a first-time founder.
edit: apparently SNI isn't supported on legacy dynos.
There are many use cases where it could actually provide value, but I found it funny that they chose to demonstrate one to the press that really afforded end-users no advantage.
The data to fight cancer is in images--specifically, gigapixel scans of tissue. Proscia is working to make pathology diagnosis more accurate and more efficient through the thoughtful application of artificial intelligence. Proscia's software is in use in laboratories today and has been adopted by world-renowned medical centers.
Our data currency is high-resolution virtual microscopy images, affording unique challenges and growth potential to all technical roles. This isn't another digital health CRUD app. If you're interested working on a meaningful problem alongside talented and good-natured colleagues, send me an email at coleman [at] proscia.com.
We offer competitive salaries, equity, health/dental/vision/disability and relocation assistance.